725
Views
76
CrossRef citations to date
0
Altmetric
Review

Clinical features and treatment of maturity onset diabetes of the young (MODY)

&
Pages 101-108 | Published online: 01 May 2012

References

  • Tattersall RB Mild familial diabetes with dominant inheritance Q J Med 1974 43 170 339 357 4212169
  • Tattersall RB Fajans SS A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people Diabetes 1975 24 1 44 53 1122063
  • Yamagata K Furuta H Oda N Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1) Nature 1996 384 6608 458 460 8945471
  • Yamagata K Oda N Kaisaki PJ Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature 1996 384 6608 455 458 8945470
  • Vionnet N Stoffel M Takeda J Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus Nature 1992 356 6371 721 722 1570017
  • Horikawa Y Iwasaki N Hara M Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY Nat Genet 1997 17 4 384 385 9398836
  • Stoffers DA Ferrer J Clarke WL Habener JF Early-onset type-II diabetes mellitus (MODY4) linked to IPF1 Nat Genet 1997 17 2 138 139 9326926
  • Shepherd M Ellis I Ahmad AM Predictive genetic testing in maturity-onset diabetes of the young (MODY) Diabet Med 2001 18 5 417 421 11472455
  • Shields BM Hicks S Shepherd MH Colclough K Hattersley AT Ellard S Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 2010 53 12 2504 2508 20499044
  • Estalella I Rica I Perez de Nanclares G Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain Clin Endocrinol (Oxf) 2007 67 4 538 546 17573900
  • Schober E Rami B Grabert M Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database Diabet Med 2009 26 5 466 473 19646184
  • Porter JR Rangasami JJ Ellard S Asian MODY: are we missing an important diagnosis? Diabet Med 2006 23 11 1257 1260 17054605
  • McDonald TJ Colclough K Brown R Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes Diabet Med 2011 28 9 1028 1033 21395678
  • Frayling TM Bulamn MP Ellard S Mutations in the hepatocyte nuclear factor-1alpha gene are a common cause of maturity-onset diabetes of the young in the UK Diabetes 1997 46 4 720 725 9075818
  • Kaisaki PJ Menzel S Lindner T Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4 Diabetes 1997 46 3 528 535 9032114
  • Lehto M Wipemo C Ivarsson SA High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes Diabetologia 1999 42 9 1131 1137 10447526
  • Gragnoli C Cockburn BN Chiaramonte F Early-onset type II diabetes mellitus in Italian families due to mutations in the genes encoding hepatic nuclear factor 1 alpha and glucokinase Diabetologia 2001 44 10 1326 1329 11692182
  • Costa A Bescos M Velho G Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families Eur J Endocrinol 2000 142 4 380 386 10754480
  • McKinney JL Cao H Robinson JF Spectrum of HNF1A and GCK mutations in Canadian families with maturity-onset diabetes of the young (MODY) Clin Invest Med 2004 27 3 135 141 15305805
  • Glucksmann MA Lehto M Tayber O Novel mutations and a mutational hotspot in the MODY3 gene Diabetes 1997 46 6 1081 1086 9166684
  • Iwasaki N Oda N Ogata M Mutations in the hepatocyte nuclear factor-1alpha/MODY3 gene in Japanese subjects with early- and late-onset NIDDM Diabetes 1997 46 9 1504 1508 9287053
  • Xu JY Dan QH Chan V Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients Eur J Hum Genet 2005 13 4 422 427 15657605
  • Pontoglio M Sreenan S Roe M Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice J Clin Invest 1998 101 10 2215 2222 9593777
  • Wang H Maechler P Hagenfeldt KA Wollheim CB Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line EMBO J 1998 17 22 6701 6713 9822613
  • Wollheim CB Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in type II diabetes Diabetologia 2000 43 3 265 277 10768087
  • Harries LW Ellard S Stride A Morgan NG Hattersley AT Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes Hum Mol Genet 2006 15 14 2216 2224 16760222
  • Stride A Ellard S Clark P Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers Diabetes Care 2005 28 7 1751 1756 15983330
  • Stride A Vaxillaire M Tuomi T The genetic abnormality in the beta cell determines the response to an oral glucose load Diabetologia 2002 45 3 427 435 11914749
  • Pontoglio M Prie D Cheret C HNF1alpha controls renal glucose reabsorption in mouse and man EMBO Rep 2000 1 4 359 365 11269503
  • Isomaa B Henricsson M Lehto M Chronic diabetic complications in patients with MODY3 diabetes Diabetologia 1998 41 4 467 473 9562352
  • Steele AM Shields BM Shepherd M Ellard S Hattersley AT Pearson ER Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene Diabet Med 2010 27 2 157 161 20546258
  • Pearson ER HDL-cholesterol: differentiating between HNF1A MODY and type 2 diabetes (abstract) 2003 20 S22 S21 S33
  • Heiervang E Folling I Sovik O Maturity-onset diabetes of the young. Studies in a Norwegian family Acta Paediatr Scand 1989 78 1 74 80 2645741
  • Sovik O Njolstad P Folling I Sagen J Cockburn BN Bell GI Hyperexcitability to sulphonylurea in MODY3 Diabetologia 1998 41 5 607 608 9628283
  • Pearson ER Liddell WG Shepherd M Corrall RJ Hattersley AT Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes Diabet Med 2000 17 7 543 545 10972586
  • Pearson ER Starkey BJ Powell RJ Gribble FM Clark PM Hattersley AT Genetic cause of hyperglycaemia and response to treatment in diabetes Lancet 2003 362 9392 1275 1281 14575972
  • Shepherd M Pearson ER Houghton J Salt G Ellard S Hattersley AT No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas Diabetes Care 2003 26 11 3191 3192 14578267
  • Shepherd M Shields B Ellard S Rubio-Cabezas O Hattersley AT A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients Diabet Med 2009 26 4 437 441 19388975
  • Tuomi T Honkanen EH Isomaa B Sarelin L Groop LC Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3 Diabetes Care 2006 29 2 189 194 16443858
  • Matschinsky FM Evolution of the glucokinase glucose sensor paradigm for pancreatic beta cells Diabetologia 1993 36 11 1215 1217 8270142
  • Byrne MM Sturis J Clement K Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations J Clin Invest 1994 93 3 1120 1130 8132752
  • Martin D Bellanne-Chantelot C Deschamps I Froguel P Robert JJ Velho G Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations (MODY2) Diabetes Care 2008 31 7 1321 1323 18411240
  • Velho G Blanche H Vaxillaire M Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families Diabetologia 1997 40 2 217 224 9049484
  • Steele AM Shields BM Shepherd M Ellard S Colclough K Hattersley AT Microvascular complication risk in patients with 50 years of moderate hyperglycaemia: are target ranges for glycaemic control appropriate? Abstract A77 Diabet Med 2011 28 S1 2 21166840
  • Hattersley AT Pearson ER Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes Endocrinology 2006 147 6 2657 2663 16556760
  • Hattersley A Bruining J Shield J Njolstad P Donaghue KC The diagnosis and management of monogenic diabetes in children and adolescents Pediatr Diabetes 2009 10 Suppl 12 33 42 19754616
  • Spyer G Hattersley AT Sykes JE Sturley RH MacLeod KM Influence of maternal and fetal glucokinase mutations in gestational diabetes Am J Obstet Gynecol 2001 185 1 240 241 11483936
  • Malecki MT Yang Y Antonellis A Curtis S Warram JH Krolewski AS Identification of new mutations in the hepatocyte nuclear factor 4alpha gene among families with early onset Type 2 diabetes mellitus Diabet Med 1999 16 3 193 200 10227563
  • Pruhova S Ek J Lebl J Genetic epidemiology of MODY in the Czech republic: new mutations in the MODY genes HNF-4alpha, GCK and HNF-1alpha Diabetologia 2003 46 2 291 295 12627330
  • Frayling TM Evans JC Bulman MP beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors Diabetes 2001 50 Suppl 1 S94 S100 11272211
  • Pearson ER Pruhova S Tack CJ Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection Diabetologia 2005 48 5 878 885 15830177
  • Carette C Dubois-Laforgue D Saint-Martin C Familial young-onset forms of diabetes related to HNF4A and rare HNF1A molecular aetiologies Diabet Med 2010 27 12 1454 1458 21105491
  • Ellard S Bellanne-Chantelot C Hattersley AT Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young Diabetologia 2008 51 4 546 553 18297260
  • Pearson ER Boj SF Steele AM Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene PLoS Med 2007 4 4 e118 17407387
  • Fajans SS Brown MB Administration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity-onset diabetes of the young Diabetes Care 1993 16 9 1254 1261 8404429
  • Coffinier C Thepot D Babinet C Yaniv M Barra J Essential role for the homeoprotein vHNF1/HNF1beta in visceral endoderm differentiation Development 1999 126 21 4785 4794 10518495
  • Ulinski T Lescure S Beaufils S Renal phenotypes related to hepatocyte nuclear factor-1beta (TCF2) mutations in a pediatric cohort J Am Soc Nephrol 2006 17 2 497 503 16371430
  • Iwasaki N Ogata M Tomonaga O Liver and kidney function in Japanese patients with maturity-onset diabetes of the young Diabetes Care 1998 21 12 2144 2148 9839108
  • Montoli A Colussi G Massa O Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor-1 beta gene: description of a new family with associated liver involvement Am J Kidney Dis 2002 40 2 397 402 12148114
  • Bellanne-Chantelot C Chauveau D Gautier JF Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations Ann Intern Med 6 2004 140 7 510 517 15068978
  • Edghill EL Bingham C Slingerland AS Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development Diabet Med 2006 23 12 1301 1306 17116179
  • Faguer S Decramer S Chassaing N Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood Kidney Int 2011 80 7 768 776 21775974
  • Goto Y Nonaka I Horai S A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies Nature 13 1990 348 6302 651 653 2102678
  • Kobayashi T Nakanishi K Nakase H In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243 Diabetes 1997 46 10 1567 1571 9313751
  • Walker M Taylor RW Stewart MW Insulin and proinsulin secretion in subjects with abnormal glucose tolerance and a mitochondrial tRNA(Leu(UUR)) mutation Diabetes Care 1995 18 11 1507 1509 8722083
  • Maassen JA ‘T Hart LM Van Essen E Mitochondrial diabetes: molecular mechanisms and clinical presentation Diabetes 2004 53 Suppl 1 S103 S109 14749274
  • Kristinsson SY Thorolfsdottir ET Talseth B MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1 Diabetologia 2001 44 11 2098 2103 11719843
  • Liu L Furuta H Minami A A novel mutation, Ser159Pro in the NeuroD1/BETA2 gene contributes to the development of diabetes in a Chinese potential MODY family Mol Cell Biochem 2007 303 1–2 115 120 17440689
  • Malecki MT Jhala US Antonellis A Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus Nat Genet 1999 23 3 323 328 10545951
  • Plengvidhya N Kooptiwut S Songtawee N PAX4 mutations in Thais with maturity onset diabetes of the young J Clin Endocrinol Metab 2007 92 7 2821 2826 17426099
  • Raeder H Johansson S Holm PI Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction Nat Genet 2006 38 1 54 62 16369531
  • Jo W Endo M Ishizu K Nakamura A Tajima T A novel PAX4 mutation in a Japanese patient with maturity-onset diabetes of the young Tohoku J Exp Med 2011 223 2 113 118 21263211
  • Cho YS Chen CH Hu C Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians Nat Genet 2012 44 1 67 72 22158537
  • Kooner JS Saleheen D Sim X Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci Nat Genet 2011 43 10 984 989 21874001
  • Saxena R Elbers CC Guo Y Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci Am J Hum Genet 2012 90 3 410 425 22325160
  • Thanabalasingham G Pal A Farmer AJ Ellard S McCarthy MI Owen KR Extending criteria for genetic testing increases diagnosis of maturity-onset diabetes of the young Diabetologia 2010 53 S63
  • Reiner AP Barber MJ Guan Y Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein Am J Hum Genet 2008 82 5 1193 1201 18439552
  • Toniatti C Demartis A Monaci P Nicosia A Ciliberto G Synergistic trans-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites EMBO J 1990 9 13 4467 4475 2265613
  • Owen KR Thanabalasingham G James TJ Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations Diabetes Care 2010 33 9 1919 1924 20724646
  • McDonald TJ Shields BM Lawry J High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes Diabetes Care 2011 34 8 1860 1862 21700917
  • Thanabalasingham G Shah N Vaxillaire M A large multicentre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes Diabetologia 2011 54 11 2801 2810 21814873
  • Bellanne-Chantelot C Levy DJ Carette C Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene J Clin Endocrinol Metab 2011 96 8 E1346 E1351 21677039
  • Schwitzgebel VM Mamin A Brun T Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1 J Clin Endocrinol Metab 2003 88 9 4398 4406 12970316
  • Thomas IH Saini NK Adhikari A Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutation Pediatr Diabetes 2009 10 7 492 496 19496967